GPT Researcher vs LynxKite

A side-by-side look at pricing, capabilities, pros, cons, and our editorial scores.

	GPT Researcher Agents	LynxKite Agents
Tagline	Open-source autonomous deep-research agent with cited long-form reports	No-code AI orchestration platform built for graph-native pipelines in drug discovery and enterprise analytics.
Category	Agents	Agents
Pricing	Free· Free and open-source (MIT License). Costs come only from your chosen LLM provider (OpenAI, Anthropic, Google, etc.) and retriever (Tavily, Bing, SerpAPI, DuckDuckGo is free).	Enterprise· Contact sales; no public pricing
Model	Model-agnostic (default GPT-4o; supports Anthropic Claude, Google Gemini, Groq, Ollama, and any LiteLLM-compatible provider)	Multi-model (LLM agents + GNNs + NVIDIA BioNeMo)
Editorial score	—	6.9 / 10
Use cases	Autonomous deep research reportsMarket research briefsCompetitive analysisLiterature reviewsDue-diligence memosGrounded context for downstream RAGMulti-source news synthesisResearch agent inside larger LLM pipelines	drug-discoverygraph-neural-networksknowledge-graphsai-workflow-orchestrationenterprise-ml-pipelines
Pros	Fully open-source (MIT) with no SaaS lock-in — self-host anywhere Model- and retriever-agnostic; swap OpenAI, Anthropic, Gemini, Ollama, Tavily, Bing, DuckDuckGo, etc. Produces long-form reports with inline citations and a source list, not just raw snippets Parallel sub-agent architecture makes multi-source research meaningfully faster than sequential prompting Ships as Python library, FastAPI service, and Next.js UI — easy to embed or run standalone Ranked #1 on CMU's DeepResearchGym (May 2025), ahead of Perplexity and OpenAI Deep Research Exports to Markdown, PDF, DOCX, and JSON out of the box	Graph-native: first-class GNNs and knowledge graphs, not bolted on GPU-accelerated via NVIDIA cuGraph and BioNeMo integrations No-code workflow builder usable by non-engineer domain experts Pre-built pharma pipelines shorten time to first model
Cons	Self-hosted only — no managed cloud, you handle deployment, keys, and quotas Token and retriever API costs add up on deep-research runs; a single long report can consume tens of thousands of tokens Quality is bounded by the LLM and retriever you choose; cheap combos produce shallow reports No built-in access control, team accounts, or audit log — you build governance yourself Latency is measured in minutes for deep research, not seconds — unsuitable for interactive chat	No public pricing; enterprise sales cycle required Current 2000:MM version is not open source (older 5.x is) Narrow sweet spot outside pharma, finance, and retail verticals
Website	gptr.dev	lynxkite.com

Pick GPT Researcher if

✅ Fully open-source (MIT) with no SaaS lock-in — self-host anywhere
✅ Model- and retriever-agnostic; swap OpenAI, Anthropic, Gemini, Ollama, Tavily, Bing, DuckDuckGo, etc.
✅ Produces long-form reports with inline citations and a source list, not just raw snippets
✅ Parallel sub-agent architecture makes multi-source research meaningfully faster than sequential prompting

Pick LynxKite if

✅ Graph-native: first-class GNNs and knowledge graphs, not bolted on
✅ GPU-accelerated via NVIDIA cuGraph and BioNeMo integrations
✅ No-code workflow builder usable by non-engineer domain experts
✅ Pre-built pharma pipelines shorten time to first model

Compare a different pair →